The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization

被引:38
|
作者
Zou, Jing [1 ]
Xie, Xuping [1 ]
Fontes-Garfias, Camila R. [1 ]
Swanson, Kena A. [2 ]
Kanevsky, Isis [2 ]
Tompkins, Kristin [2 ]
Cutler, Mark [2 ]
Cooper, David [2 ]
Dormitzer, Philip R. [2 ]
Shi, Pei-Yong [1 ,3 ,4 ,5 ]
机构
[1] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA
[2] Pfizer, Pearl River, NY 10965 USA
[3] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA
[4] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA
[5] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA
关键词
D O I
10.1038/s41541-021-00313-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Initial COVID-19 vaccine candidates were based on the original sequence of SARS-CoV-2. However, the virus has since accumulated mutations, among which the spike D614G is dominant in circulating virus, raising questions about potential virus escape from vaccine-elicited immunity. Here, we report that the D614G mutation modestly reduced (1.7-2.4-fold) SARS-CoV-2 neutralization by BNT162b2 vaccine-elicited mouse, rhesus, and human sera, concurring with the 95% vaccine efficacy observed in clinical trial.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Functional importance of the D614G mutation in the SARS-CoV-2 spike protein
    Jackson, Cody B.
    Zhang, Lizhou
    Farzan, Michael
    Choe, Hyeryun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 538 : 108 - 115
  • [32] Neutralization of alpha, gamma, and D614G SARS-CoV-2 variants by CoronaVac vaccine-induced antibodies
    Fernandez, Jorge
    Bruneau, Nicole
    Fasce, Rodrigo
    San Martin, Hector
    Balanda, Monserrat
    Bustos, Patricia
    Ulloa, Soledad
    Mora, Judith
    Ramirez, Eugenio
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (01) : 399 - 403
  • [33] BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants
    Liu, Yang
    Liu, Jianying
    Xia, Hongjie
    Zhang, Xianwen
    Zou, Jing
    Fontes-Garfias, Camila R.
    Weaver, Scott C.
    Swanson, Kena A.
    Cai, Hui
    Sarkar, Ritu
    Chen, Wei
    Cutler, Mark
    Cooper, David
    Muik, Alexander
    Sahin, Ugur
    Jansen, Kathrin U.
    Xie, Xuping
    Dormitzer, Philip R.
    Shi, Pei-Yong
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (05): : 472 - 474
  • [34] BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
    Jianying Liu
    Yang Liu
    Hongjie Xia
    Jing Zou
    Scott C. Weaver
    Kena A. Swanson
    Hui Cai
    Mark Cutler
    David Cooper
    Alexander Muik
    Kathrin U. Jansen
    Ugur Sahin
    Xuping Xie
    Philip R. Dormitzer
    Pei-Yong Shi
    Nature, 2021, 596 : 273 - 275
  • [35] BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
    Liu, Jianying
    Liu, Yang
    Xia, Hongjie
    Zou, Jing
    Weaver, Scott C.
    Swanson, Kena A.
    Cai, Hui
    Cutler, Mark
    Cooper, David
    Muik, Alexander
    Jansen, Kathrin U.
    Sahin, Ugur
    Xie, Xuping
    Dormitzer, Philip R.
    Shi, Pei-Yong
    NATURE, 2021, 596 (7871) : 273 - +
  • [36] Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients
    Marinaki, Smaragdi
    Adamopoulos, Stamatis
    Degiannis, Dimitrios
    Roussos, Sotirios
    Pavlopoulou, Ioanna D.
    Hatzakis, Angelos
    Boletis, Ioannis N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (08) : 2913 - 2915
  • [37] Comparative Immunogenicity of BNT162b2 mRNA Vaccine with Natural SARS-CoV-2 Infection
    Psichogiou, Mina
    Karabinis, Andreas
    Poulakou, Garyphallia
    Antoniadou, Anastasia
    Kotanidou, Anastasia
    Degiannis, Dimitrios
    Pavlopoulou, Ioanna D.
    Chaidaroglou, Antigoni
    Roussos, Sotirios
    Mastrogianni, Elpida
    Eliadi, Irene
    Basoulis, Dimitrios
    Petsios, Konstantinos
    Leontis, Konstantinos
    Kakalou, Eleni
    Protopapas, Konstantinos
    Jahaj, Edison
    Pratikaki, Maria
    Syrigos, Konstantinos N.
    Lagiou, Pagona
    Gogas, Helen
    Tsiodras, Sotirios
    Magiorkinis, Gkikas
    Paraskevis, Dimitrios
    Sypsa, Vana
    Hatzakis, Angelos
    VACCINES, 2021, 9 (09)
  • [38] SARS-CoV-2 Omicron-neutralizing memory B cells are elicited by two doses of BNT162b2 mRNA vaccine
    Kotaki, Ryutaro
    Adachi, Yu
    Moriyama, Saya
    Onodera, Taishi
    Fukushi, Shuetsu
    Nagakura, Takaki
    Tonouchi, Keisuke
    Terahara, Kazutaka
    Sun, Lin
    Takano, Tomohiro
    Nishiyama, Ayae
    Shinkai, Masaharu
    Oba, Kunihiro
    Nakamura-Uchiyama, Fukumi
    Shimizu, Hidefumi
    Suzuki, Tadaki
    Matsumura, Takayuki
    Isogawa, Masanori
    Takahashi, Yoshimasa
    SCIENCE IMMUNOLOGY, 2022, 7 (70)
  • [39] Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine
    Dias, Leonor
    Soares-Dos-Reis, Ricardo
    Meira, Joao
    Ferrao, Diana
    Soares, Pedro Ribeirinho
    Pastor, Ana
    Gama, Guilherme
    Fonseca, Luisa
    Fagundes, Vitor
    Carvalho, Marta
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (08):
  • [40] Effectiveness of BNT162b2 vaccine against SARS-CoV-2 among healthcare workers
    Sansone, Emanuele
    Sala, Emma
    Tiraboschi, Mara
    Albini, Elisa
    Lombardo, Massimo
    Indelicato, Annamaria
    Rosati, Cristina
    Boniotti, Maria Beatrice
    Castelli, Francesco
    De Palma, Giuseppe
    MEDICINA DEL LAVORO, 2021, 112 (03): : 250 - 255